Publications for Marcus Bäck
Co-author map based on ISI articles 2007-

Journal Articles

Veronica Sandgren, Marcus Bäck, Ingemar Kvarnström and Anders Dahlgren
  Design and synthesis of hydroxyethylene-based BACE-1 inhibitors incorporating extended P1 substituents
  Open Medicinal Chemistry Journal, 2013, 7, 1-15.
   Fulltext  PDF  

Marcus Bäck, Jonas Nyhlén, Ingemar Kvarnström, Sara Appelgren, Neera Borkakoti, Katarina Jansson, Jimmy Lindberg, Susanne Nyström, Anders Hallberg, Åsa Rosenquist and Bertil Samuelsson
  Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
  Bioorganic & medicinal chemistry, 2008, 16(21), 9471-9486.
 Web of Science® Times Cited: 20

Marcus Bäck, Per-Ola Johansson, Fredrik Wångsell, Fredrik Thorstensson, Ingemar Kvarnström, Susana Ayesa, Horst Wähling, Mikael Pelcman, Katarina Jansson, Stefan Lindström, Hans Wallberg, Björn Classon, Christina Rydergård, Lotta Vrang, Elizabeth Hamelink, Anders Hallberg, Åsa Rosenquist and Bertil Samuelsson
  Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.
  Bioorganic & Medicinal Chemistry, 2007, 15(22), 7184-7202.
 Web of Science® Times Cited: 16

Per-Ola Johansson, Marcus Bäck, Ingemar Kvarnström, Katarina Jansson, Lotta Vrang, Elizabeth Hamelink, Anders Hallberg, Åsa Rosenqvist and Bertil Samuelsson
  Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template
  Bioorganic & Medicinal Chemistry, 2006, 14(15), 5136-5151.
 Web of Science® Times Cited: 17

Ph.D. Theses

Marcus Bäck
  Design and Synthesis of Inhibitors Targeting the Hepatitis C Virus NS3 Serine Protease and the Aspartic Protease BACE-1
  2009.


  Fulltext PDF

Licentiate Theses

Marcus Bäck
  Design and Synthesis of Hepatitis C Virus NS3 Protease Inhibitors Incorporating a P2 Cyclopentane-Derived Scaffold
  2006.


  Fulltext PDF